PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
Eotaxin-2/CCL24 19 Target Disease Psoriasis 26,882 1 0.00 -0.97 0.05 0.60
Des (1-6) IGF-II 18 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -0.97 0.06 0.65
Allopurinol (Zyloprim)- FDA 18 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
Allopurinol (Zyloprim)- FDA 18 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.06 0.56
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target D(2) Dopamine Receptor 1,559 1 0.01 -0.97 0.06 0.68
BMP-2B 18 Target Target BMP-6 386 1 0.01 -0.97 0.06 0.72
BMP-2B 18 Target Target BMP-7 1,112 2 0.01 -0.94 0.11 0.71
BMP-2B 18 Target Target Collagen 138,882 6 0.00 -0.82 0.33 0.61
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
BMP-2B 18 Target Target Activin A 2,048 1 0.01 -0.97 0.06 0.67
Des (1-6) IGF-II 18 Target Target Collagen 138,882 1 0.00 -0.97 0.06 0.57
Allopurinol (Zyloprim)- FDA 18 Drug Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Target Collagen 138,882 3 0.00 -0.91 0.17 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
BMP-2B 18 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.06 0.63
Allopurinol (Zyloprim)- FDA 18 Drug Disease Pain 409,851 2 0.00 -0.94 0.11 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Epilepsy 71,172 2 0.00 -0.94 0.11 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Constipation 15,810 1 0.00 -0.97 0.06 0.62
Aldactone (Spironolactone)- FDA 18 Drug Target Aldosterone Receptor 528 1 0.01 -0.97 0.06 0.71
Aldactone (Spironolactone)- FDA 18 Drug Disease Cancer 1,053,491 2 0.00 -0.94 0.11 0.54
Aldactone (Spironolactone)- FDA 18 Drug Disease Depression 220,092 1 0.00 -0.97 0.06 0.56
Aldactone (Spironolactone)- FDA 18 Drug Disease Acne 11,364 4 0.01 -0.88 0.22 0.66
Anesthesia Local 18 Disease Disease Sedation 27,984 2 0.00 -0.94 0.11 0.62
Anesthesia Local 18 Disease Disease Bronchitis 18,336 1 0.00 -0.97 0.06 0.61
Abatacept (Orencia)- FDA 18 Drug Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.17 -0.69 0.50 0.86
Carcinoma Brain 18 Disease Disease Carcinoma 433,099 18 0.01 -0.23 1.00 0.61
Abatacept (Orencia)- FDA 18 Drug Disease Rheumatoid Arthritis 78,952 8 0.01 -0.75 0.44 0.63
Abatacept (Orencia)- FDA 18 Drug Disease Hepatitis 163,842 2 0.00 -0.94 0.11 0.58
Abatacept (Orencia)- FDA 18 Drug Disease Neutropenia 25,934 1 0.00 -0.97 0.06 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Pain 409,851 2 0.00 -0.94 0.11 0.56
Abatacept (Orencia)- FDA 18 Drug Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.06 0.65
Anesthesia Local 18 Disease Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
Anesthesia Local 18 Disease Disease Hemorrhage 100,979 2 0.00 -0.94 0.11 0.59
Anesthesia Local 18 Disease Target CEA 17,022 1 0.00 -0.97 0.06 0.61
Carcinoma Brain 18 Disease Disease Cancer 1,053,491 5 0.00 -0.85 0.28 0.56
Carcinoma Brain 18 Disease Disease Prostate Cancer 71,064 1 0.00 -0.97 0.06 0.58
Carcinoma Brain 18 Disease Disease Lung Carcinoma 13,423 2 0.00 -0.94 0.11 0.64
Anesthesia Local 18 Disease Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
Abatacept (Orencia)- FDA 18 Drug Disease Inflammation 252,734 2 0.00 -0.94 0.11 0.57
Carcinoma Brain 18 Disease Disease Epilepsy 71,172 1 0.00 -0.97 0.06 0.58
Anesthesia Local 18 Disease Disease Breast Cancer 173,695 1 0.00 -0.97 0.06 0.56
Carcinoma Brain 18 Disease Disease Breast Cancer 173,695 1 0.00 -0.97 0.06 0.56
Carcinoma Brain 18 Disease Disease Brain Tumors 16,749 1 0.00 -0.97 0.06 0.61
Carcinoma Brain 18 Disease Disease Lung Cancer 91,416 2 0.00 -0.94 0.11 0.59
Anesthesia Local 18 Disease Disease Hypotension 42,123 1 0.00 -0.97 0.06 0.59
Carcinoma Brain 18 Disease Target CD34 24,598 1 0.00 -0.97 0.06 0.61
Aldactone (Spironolactone)- FDA 18 Drug Disease Arrhythmia 29,330 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Target Angiotensin Converting Enzyme 31,674 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Drug Atorvastatin Calcium (Lipitor)- FDA 28 1 0.04 -0.95 0.06 0.82
Aldactone (Spironolactone)- FDA 18 Drug Drug Drospirenone 514 2 0.02 -0.94 0.11 0.74
Allopurinol (Zyloprim)- FDA 18 Drug Disease Gout 8,355 7 0.02 -0.78 0.39 0.69
Allopurinol (Zyloprim)- FDA 18 Drug Disease Arthritis 128,324 3 0.00 -0.91 0.17 0.59
Allopurinol (Zyloprim)- FDA 18 Drug Target Xanthine Oxidase 8,860 4 0.01 -0.88 0.22 0.67
Allopurinol (Zyloprim)- FDA 18 Drug Disease Renal Failure 73,993 2 0.00 -0.94 0.11 0.60
Anesthesia Local 18 Disease Disease Nausea 42,627 1 0.00 -0.97 0.06 0.59
Anesthesia Local 18 Disease Disease Cancer 1,053,491 1 0.00 -0.97 0.06 0.53
Anesthesia Local 18 Disease Disease Infection 766,637 1 0.00 -0.97 0.06 0.53
Anesthesia Local 18 Disease Disease Stroke 146,992 1 0.00 -0.97 0.06 0.57
Aldactone (Spironolactone)- FDA 18 Drug Disease Infertility 35,448 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Drug Amiloride (Midamor)- FDA 6 1 0.10 -0.89 0.17 0.85
Aldactone (Spironolactone)- FDA 18 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Aldactone (Spironolactone)- FDA 18 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.03 -0.96 0.06 0.80
Aldactone (Spironolactone)- FDA 18 Drug Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
Aldactone (Spironolactone)- FDA 18 Drug Target Renin 43,456 1 0.00 -0.97 0.06 0.59
Aldactone (Spironolactone)- FDA 18 Drug Target CHK2 1,391 1 0.01 -0.97 0.06 0.68
Aldactone (Spironolactone)- FDA 18 Drug Disease Ventricular Dysfunction 12,856 1 0.00 -0.97 0.06 0.62
Aldactone (Spironolactone)- FDA 18 Drug Drug Amiloride Hydrochloride (Amiloride Hydrochloride)- FDA 6 1 0.10 -0.89 0.17 0.85
Aldactone (Spironolactone)- FDA 18 Drug Drug Amlodipine Besylate Atorvastatin Calcium (Caduet)- FDA 1 1 0.24 -0.69 1.00 0.86
Aldactone (Spironolactone)- FDA 18 Drug Drug Alprazolam (Xanax)- FDA 8 2 0.17 -0.82 0.25 0.88
Carcinoma Brain 18 Disease Disease Glioblastoma 17,933 2 0.00 -0.94 0.11 0.63
Aldactone (Spironolactone)- FDA 18 Drug Drug Amlodipine Besylate (Norvasc)- FDA 28 1 0.04 -0.95 0.06 0.82
Angiostatin K1-3 17 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Angiostatin K1-3 17 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
Avonex (Interferon beta-1a)- FDA 17 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Angiostatin K1-3 17 Target Target ETS1 539 1 0.01 -0.97 0.06 0.71
Angiostatin K1-3 17 Target Target DAPK1 205 1 0.02 -0.97 0.06 0.75
Angiostatin K1-3 17 Target Target Collagen 138,882 1 0.00 -0.97 0.06 0.57
Angiostatin K1-3 17 Target Disease Cancer 1,053,491 7 0.00 -0.77 0.41 0.57
Vitamin D Receptor Interacting Protein 17 Target Disease Breast Cancer 173,695 2 0.00 -0.94 0.12 0.58
Angiostatin K1-3 17 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
Angiostatin K1-3 17 Target Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
beta-Cellulin 17 Target Disease Mesothelioma 11,198 2 0.00 -0.94 0.12 0.64
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Thromboembolic Disease 3,336 1 0.00 -0.97 0.06 0.66
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Drug Angiomax (Bivalirudin)- FDA 13 5 0.35 -0.65 0.38 0.93
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Stroke 146,992 3 0.00 -0.90 0.19 0.59
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Renal Failure 73,993 1 0.00 -0.97 0.06 0.58
Pancreatitis Chronic 16 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Pancreatitis Chronic 16 Disease Disease Pain 409,851 5 0.00 -0.83 0.31 0.58
Pancreatitis Chronic 16 Disease Target Erbb2 4,536 1 0.00 -0.97 0.06 0.65